Cargando…

Prevalence of Chagas heart disease in dilated cardiomyopathy

OBJECTIVES: The main objective is to determine the prevalence of American trypanosomiasis in patients with dilated cardiomyopathy in a tertiary hospital in western Mexico. METHODS: From January 1991 to February 2016, 387 consecutive patients with a confirmed diagnosis of dilated cardiomyopathy were...

Descripción completa

Detalles Bibliográficos
Autores principales:	González-Zambrano, Héctor, Amaya-Tapia, Gerardo, Franco-Ramos, María C., López León-Murguía, Oscar J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Permanyer Publications 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258910/ https://www.ncbi.nlm.nih.gov/pubmed/33079075 http://dx.doi.org/10.24875/ACM.20000042

Ejemplares similares

Measurement of multiple cytokines for discrimination and risk stratification in patients with Chagas’ disease and idiopathic dilated cardiomyopathy
por: Wang, Yong, et al.
Publicado: (2021)

Distinct monocyte subset phenotypes in patients with different clinical forms of chronic Chagas disease and seronegative dilated cardiomyopathy
por: Pérez-Mazliah, Damián E., et al.
Publicado: (2018)

Peripartum cardiomyopathy and dilated cardiomyopathy: different at heart
por: Bollen, Ilse A. E., et al.
Publicado: (2015)

Treatment of Chagas Cardiomyopathy
por: Botoni, Fernando A., et al.
Publicado: (2013)

Chagas Cardiomyopathy: From Romaña Sign to Heart Failure and Sudden Cardiac Death
por: Pino-Marín, Antonia, et al.
Publicado: (2021)

Prevalence of Anemia in Children with Congestive Heart Failure due to Dilated Cardiomyopathy
por: Mueller, Goetz Christoph, et al.
Publicado: (2012)

Chagas Disease Cardiomyopathy: Immunopathology and Genetics
por: Cunha-Neto, Edecio, et al.
Publicado: (2014)

Chronic Chagas cardiomyopathy
por: Aiello, Vera Demarchi, et al.
Publicado: (2015)

MitraClip(®) as bridging strategy for heart transplantation in Chagas cardiomyopathy: a case report
por: Vasquez-Rodríguez, Juan Felipe, et al.
Publicado: (2020)

Prevalence of Celiac Disease in Children with Idiopathic Dilated Cardiomyopathy
por: Zahmatkeshan, Mozhgan, et al.
Publicado: (2014)

Scientometrics analysis of research activity and collaboration patterns in Chagas cardiomyopathy
por: González-Alcaide, Gregorio, et al.
Publicado: (2018)

Metabolomic Profiling of End-Stage Heart Failure Secondary to Chronic Chagas Cardiomyopathy
por: Díaz, Martha Lucía, et al.
Publicado: (2022)

Biomakers in Chronic Chagas Cardiomyopathy
por: Rodrigues, Angela Braga, et al.
Publicado: (2022)

Speckle tracking echocardiographic deformation indices in Chagas and idiopathic dilated cardiomyopathy: Incremental prognostic value of longitudinal strain
por: Santos Junior, Omar Ribeiro, et al.
Publicado: (2019)

Chagas Cardiomyopathy in the Context of the Chronic Disease Transition
por: Hidron, Alicia I., et al.
Publicado: (2010)

Cognitive dysfunction in chronic Chagas disease cardiomyopathy
por: Dias, Jesângeli Sousa, et al.
Publicado: (2009)

Heart failure in dilated non-ischaemic cardiomyopathy
por: Seferović, Petar M, et al.
Publicado: (2019)

Clinical Presentations of Chagas Cardiomyopathy
por: Shehadeh, Malik, et al.
Publicado: (2020)

Impairment of Multiple Mitochondrial Energy Metabolism Pathways in the Heart of Chagas Disease Cardiomyopathy Patients
por: Teixeira, Priscila Camillo, et al.
Publicado: (2021)

Myocardial Involvement in Chagas Disease and Insulin Resistance: A Non-Metabolic Model of Cardiomyopathy
por: Echeverría, Luis E., et al.
Publicado: (2020)

Mortality risk in dilated cardiomyopathy: the accuracy of heart failure prognostic models and dilated cardiomyopathy‐tailored prognostic model
por: Dziewięcka, Ewa, et al.
Publicado: (2020)

T-Cell Subpopulations Exhibit Distinct Recruitment Potential, Immunoregulatory Profile and Functional Characteristics in Chagas versus Idiopathic Dilated Cardiomyopathies
por: Neves, Eula G. A., et al.
Publicado: (2022)

Dilated cardiomyopathy
por: Schultheiss, Heinz-Peter, et al.
Publicado: (2019)

Immunoadsorption Therapy for Patients with Dilated Cardiomyopathy and Heart Failure
por: Ikeda, Uichi, et al.
Publicado: (2008)

Genetics and genomics of dilated cardiomyopathy and systolic heart failure
por: Tayal, Upasana, et al.
Publicado: (2017)

Dilated Cardiomyopathy: Beware of Diet Drugs Slimming the Heart
por: Bhattad, Pradnya Brijmohan, et al.
Publicado: (2023)

Differences in virus prevalence and load in the hearts of patients with chronic dilated cardiomyopathy with and without immune-mediated inflammatory disease
por: Dennert, R, et al.
Publicado: (2010)

Comprehensive analysis of three TYK2 gene variants in the susceptibility to Chagas disease infection and cardiomyopathy
por: Leon Rodriguez, Daniel A., et al.
Publicado: (2018)

Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
por: Sun, Yang, et al.
Publicado: (2021)

Dilated Cardiomyopathy and Systolic Heart Failure in a Female Patient With Danon Disease
por: Stack-Pyle, Taylor J, et al.
Publicado: (2022)

Effects of Exercise Training on Heart Rate Variability in Chagas Heart Disease
por: Nascimento, Bruno Ramos, et al.
Publicado: (2014)

Dilated cardiomyopathies and non-compaction cardiomyopathy
por: Hänselmann, A., et al.
Publicado: (2020)

Advanced management of ventricular arrhythmias in chronic Chagas cardiomyopathy
por: Santacruz, David, et al.
Publicado: (2021)

Plasma microrna expression profile for reduced ejection fraction in dilated cardiomyopathy
por: Calderon-Dominguez, Maria, et al.
Publicado: (2021)

Heart-specific deletion of CENP-F causes dilated cardiomyopathy
Publicado: (2012)

Survival benefit of ghrelin in the heart failure due to dilated cardiomyopathy
por: Du, Cheng-Kun, et al.
Publicado: (2014)

Heart rate manipulation in dilated cardiomyopathy: Assessing the role of Ivabradine
por: Raja, Deep Chandh, et al.
Publicado: (2018)

Maintaining Success for Patients With Dilated Cardiomyopathy and Remission of Heart Failure
por: Halliday, Brian P., et al.
Publicado: (2022)

Circulating circRNA as biomarkers for dilated cardiomyopathy etiology
por: Costa, Marina C., et al.
Publicado: (2021)

Cardiovascular biomarkers as predictors of adverse outcomes in chronic Chagas cardiomyopathy
por: Echeverría, Luis E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_geqrhfj9e1721565vdedreoe2t